The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Progesterone modulates a neuronal nicotinic acetylcholine receptor.
Open accessAbstract
The major brain nicotinic acetylcholine receptor is assembled from two subunits termed alpha 4 and n alpha 1. When expressed in Xenopus oocytes, these subunits reconstitute a functional acetylcholine receptor that is inhibited by progesterone levels similar to those found in serum. In this report, we show that the steroid interacts with a site located on the extracellular part of the protein, thus confirming that inhibition by progesterone is not due to a nonspecific perturbation of the membrane bilayer or to the activation of second messengers. Because inhibition by progesterone does not require the presence of agonist, is voltage-independent, and does not alter receptor desensitization, we conclude that the steroid is not an open channel blocker. In addition, we show that progesterone is not a competitive inhibitor but may interact with the acetylcholine binding site and that its effect is independent of the ionic permeability of the receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Membrane Actions of Anesthetics and Tranquilizers
Seeman, P. (1972) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06931-5 · Cited by 2,246
Rings of negatively charged amino acids determine the acetylcholine receptor channel conductance
Imoto, K., Busch, C., Sakmann, B., Mishina, M., Konno, T., Nakai, J., Bujo, H., Mori, Y., Fukuda, K., & Numa, S. (1988) · Nature · doi:10.1038/335645a0 · Cited by 794
Harrison, N. L., Majewska, M. D., Harrington, J. W., & Barker, J. L. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00332-5 · Cited by 611
Neurosteroids: A new brain function?
Baulieu, E.-E., & Robel, P. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90490-c · Cited by 536
Neurosteroids act on recombinant human GABAA receptors
Puia, G., Santi, M., Vicini, S., Pritchett, D. B., Purdy, R. H., Paul, S. M., Seeburg, P. H., & Costa, E. (1990) · Neuron · doi:10.1016/0896-6273(90)90202-q · Cited by 519
Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor
Cooper, E., Couturier, S., & Ballivet, M. (1991) · Nature · doi:10.1038/350235a0 · Cited by 469
Self-citationGee, K. W., Bolger, M. B., Brinton, R. E., Coirini, H., & McEwen, B. S. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22167-x · Cited by 466
The structure of ion channels in membranes of excitable cells
Unwin, N. (1989) · Neuron · doi:10.1016/0896-6273(89)90235-3 · Cited by 370
Correlation between acetylcholine receptor function and structural properties of membranes
Fong, T. M., & McNamee, M. G. (1986) · Biochemistry · doi:10.1021/bi00352a015 · Cited by 305
Ascher, P., Large, W. A., & Rang, H. P. (1979) · The Journal of Physiology · doi:10.1113/jphysiol.1979.sp012958 · Cited by 291
Cited by
Nicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous System
Dani, J. A., & Bertrand, D. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105214 · Cited by 1,197
Self-citationAcetylcholine beyond neurons: the non‐neuronal cholinergic system in humans
Wessler, I., & Kirkpatrick, C. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.185 · Cited by 855
Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives
Rupprecht, R., & Holsboer, F. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01399-5 · Cited by 633
NEUROSTEROIDS: A NOVEL FUNCTION OF THE BRAIN
Baulieu, E. E. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(98)00071-7 · Cited by 622
Nicotinic acetylcholine receptors: from structure to brain function
Hogg, R. C., Raggenbass, M., & Bertrand, D. (2003) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0005-1 · Cited by 528
Self-citationInhibition of oxytocin receptor function by direct binding of progesterone
Grazzini, E., Guillon, G., Mouillac, B., & Zingg, H. H. (1998) · Nature · doi:10.1038/33176 · Cited by 466
Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties
Rupprecht, R. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00064-1 · Cited by 427
Human neuronal nicotinic receptors
Gotti, C., Fornasari, D., & Clementi, F. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00034-8 · Cited by 416
Sex differences in nicotine effects and self-administration: Review of human and animal evidence
Perkins, K., Donny, E., & Caggiula, A. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011431 · Cited by 387
Mensah-Nyagan, A. G., Do-Rego, J.-L., Beaujean, D., Luu-The, V., Pelletier, G., & Vaudry, H. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01395-4 · Cited by 379
Rapid Actions of Steroid Receptors in Cellular Signaling Pathways
Cato, A. C. B., Nestl, A., & Mink, S. (2002) · Science's STKE · doi:10.1126/stke.2002.138.re9 · Cited by 369
Do Rego, J. L., Seong, J. Y., Burel, D., Leprince, J., Luu-The, V., Tsutsui, K., Tonon, M.-C., Pelletier, G., & Vaudry, H. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.006 · Cited by 357
Neurosteroids: Beginning of the story
Baulieu, E. E., Robel, P., & Schumacher, M. (2001) · International Review of Neurobiology · doi:10.1016/s0074-7742(01)46057-0 · Cited by 352
Brain nicotinic receptors: structure and regulation, role in learning and reinforcement
Changeux, J.-P., Bertrand, D., Corringer, P.-J., Dehaene, S., Edelstein, S., Léna, C., Le Novère, N., Marubio, L., Picciotto, M., & Zoli, M. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00040-4 · Cited by 322
Self-citationIvermectin: A Positive Allosteric Effector of the α7 Neuronal Nicotinic Acetylcholine Receptor
Krause, R. M., Buisson, B., Bertrand, S., Corringer, P.-J., Galzi, J.-L., Changeux, J.-P., & Bertrand, D. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.2.283 · Cited by 320
Self-citationRobel, P., & Baulieu, E.-E. (1994) · Trends in Endocrinology & Metabolism · doi:10.1016/1043-2760(94)90114-7 · Cited by 310
Neuronal nicotinic receptors: Molecular organization and regulations
Galzi, J.-L., & Changeux, J.-P. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00034-4 · Cited by 260
Allosteric modulation of nicotinic acetylcholine receptors
Bertrand, D., & Gopalakrishnan, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.011 · Cited by 255
Self-citationSteroids, neuroactive steroids and neurosteroids in psychopathology
Dubrovsky, B. O. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.001 · Cited by 250
Neuroprotective strategies for retinal disease
Pardue, M. T., & Allen, R. S. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.02.002 · Cited by 237
“, 1998), and at nicotinic acetylcholine receptors as a modulator of activity (Valera et al., 1992).”
Guennoun, R., Fiddes, R. J., Gouézou, M., Lombès, M., & Baulieu, E.-E. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00016-l · Cited by 208
Tribollet, E., Bertrand, D., Marguerat, A., & Raggenbass, M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.09.028 · Cited by 199
Self-citationEhring, G. R., Kerschbaum, H. H., Eder, C., Neben, A. L., Fanger, C. M., Khoury, R. M., Negulescu, P. A., & Cahalan, M. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1593 · Cited by 163
Ukena, K., Kohchi, C., & Tsutsui, K. (1999) · Endocrinology · doi:10.1210/endo.140.2.6516 · Cited by 141
Developmental regulation of nicotinic acetylcholine receptors within midbrain dopamine neurons
Azam, L., Chen, Y., & Leslie, F. M. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.011 · Cited by 138
A kinetic mechanism for nicotinic acetylcholine receptors based on multiple allosteric transitions.
Edelstein, S. J., Schaad, O., Henry, E., Bertrand, D., & Changeux, J.-P. (1996) · Biological Cybernetics · doi:10.1007/s004220050302 · Cited by 134
Self-citationSex‐dependent effects of nicotine on the developing brain
Cross, S. J., Linker, K. E., & Leslie, F. M. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23878 · Cited by 104
“Progesterone and its A-ring metabolites dose-dependently inhibit function of a3b4 and a4b2 nAChRs (Valera et al., 1992; Ke and Lukas, 1996; Paradiso et al., 2000), although physiological levels of progesterone may not be sufficient to inhibit a4b2 nAChRs (Paradiso et al.”
BackgroundChapter 4 Cholesterol and steroid hormones: modulators of oxytocin receptor function
Gimpl, G., Wiegand, V., Burger, K., & Fahrenholz, F. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)39006-x · Cited by 81
Progesterone modulation of α5 nAChR subunits influences anxiety‐related behavior during estrus cycle
Gangitano, D., Salas, R., Teng, Y., Perez, E., & De Biasi, M. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2009.00476.x · Cited by 76
“It has been previously reported that progesterone can block nAChRs expressed in Xenopus oocytes via allosteric mechanisms (Ke & Lukas 1996; Valera et al. 1992).”
BackgroundIbanez, C., Guennoun, R., Liere, P., Eychenne, B., Pianos, A., El-Etr, M., Baulieu, E.-E., & Schumacher, M. (2003) · Endocrinology · doi:10.1210/en.2002-0073 · Cited by 56
Cosgrove, K. P., Mitsis, E. M., Bois, F., Frohlich, E., Tamagnan, G. D., Krantzler, E., Perry, E., Maciejewski, P. K., Epperson, C. N., Allen, S., et al. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.042317 · Cited by 31
Moen, J. K., & Lee, A. M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.745783 · Cited by 30
Metadata
- Authors
- Valera, S., Ballivet, M., & Bertrand, D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1992-10-15
- Volume
- 89
- Issue
- 20
- Pages
- 9949-9953
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2001853114
- Cited by
- 273
- References
- 32
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.